Related Experiment Video
Updated: May 31, 2026

Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications
Published on: June 29, 2020
CD4saurus Rex &HIVelociraptor vs. development of clinically useful immunological markers: a Jurassic tale of frozen
Andrea De Maria1, Andrea Cossarizza
1Centro di Eccellenza per la Ricerca Biomedica, Università di Genova, Genova, Italy. de-maria@unige.it
Insights
CD4 T cell counts have limitations in managing HIV patients, impacting treatment decisions. New immunological parameters require validation to improve patient care beyond current CD4 testing methods.
Area of Science:
- Immunology
- HIV Medicine
- Clinical Trials
Background:
- CD4 T cell counts are widely used to assess immune status in HIV patients.
- Despite their utility, CD4 counts have significant clinical and immunological limitations in specific scenarios.
- These limitations include identifying nonresponders, predicting cancer risk, and guiding treatment simplification.
Purpose of the Study:
- To highlight the limitations of CD4 T cell counts in HIV clinical practice.
- To advocate for the exploration and validation of novel immunological parameters.
- To encourage the evolution of immune monitoring beyond traditional CD4 testing.
Main Methods:
- Review of existing literature on CD4 T cell count utility and limitations.
- Discussion of alternative immunogenetic and innate immune parameters.
- Emphasis on the need for validation of new parameters in larger clinical trials.
Main Results:
- CD4 counts are insufficient for certain clinical decisions in HIV management.
- Existing historical and novel immune parameters show potential for improved patient management.
- Lack of validation hinders the integration of advanced immunological tests into clinical practice.
Conclusions:
- There is a critical need to move beyond the "CD4saurus Rex" era in HIV immunology.
- New immunological parameters, including immunogenotypic and innate immune markers, require rigorous validation.
- Clinical adoption of validated, advanced immunological tests is essential for optimizing HIV patient care.
Abstract:
One of the most neglected areas of everyday clinical practice for HIV physicians is unexpectedly represented by CD4 T cell counts when used as an aid to clinical decisions. All who care for HIV patients believe that CD4+ T cell counts are a reliable method to evaluate a patient immune status. There is however a fatalistic acceptance that besides its general usefulness, CD4+ T cell counts have relevant clinical and immunological limits. Shortcomings of CD4 counts appear in certain clinical scenarios including identification of immunological nonresponders, subsequent development of cancer on antiretroviral treatment, failure on treatment simplification. Historical and recently described parameters might be better suited to advise management of patients at certain times during their disease history. Immunogenotypic parameters and innate immune parameters that define progression as well as immune parameters associated with immune recovery are available and have not been introduced into validation processes in larger trials. The scientific and clinical community needs an effort in stimulating clinical evolution of immunological tests beyond "CD4saurus Rex" introducing new parameters in the clinical arena after appropriate validation.
More Related Videos
Related Concept Videos
The Fossil Record
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The Evidence for Evolution
Evolution of New Traits in Microbes
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Evolutionary Relationships through Genome Comparisons

